SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-21-000414
Filing Date
2021-02-08
Accepted
2021-02-05 17:33:44
Documents
74
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 10-K organicell_10k.htm 10-K 1292656
2 EXHIBIT 21.1 organicell_ex21-1.htm EX-21.1 12155
3 EXHIBIT 31.1 organicell_ex31-1.htm EX-31.1 15060
4 EXHIBIT 31.2 organicell_ex31-2.htm EX-31.2 14916
5 EXHIBIT 32.1 organicell_ex32-1.htm EX-32.1 6329
6 EXHIBIT 32.2 organicell_ex32-2.htm EX-32.2 6382
13 GRAPHIC image_001.jpg GRAPHIC 74751
  Complete submission text file 0001829126-21-000414.txt   5376037

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bpsr-20201031.xml EX-101.INS 720668
8 XBRL SCHEMA FILE bpsr-20201031.xsd EX-101.SCH 55113
9 XBRL CALCULATION FILE bpsr-20201031_cal.xml EX-101.CAL 64769
10 XBRL DEFINITION FILE bpsr-20201031_def.xml EX-101.DEF 211983
11 XBRL LABEL FILE bpsr-20201031_lab.xml EX-101.LAB 348171
12 XBRL PRESENTATION FILE bpsr-20201031_pre.xml EX-101.PRE 307340
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-55008 | Film No.: 21597504
SIC: 3790 Miscellaneous Transportation Equipment